Holen Sie sich die Stockscreener-App
83.89
0.55%
-0.46
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$84.35
Offen:
$85.11
24-Stunden-Volumen:
3.48M
Relative Volume:
0.86
Marktkapitalisierung:
$40.78B
Einnahmen:
$6.13B
Nettoeinkommen (Verlust:
$272.21M
KGV:
151.95
EPS:
0.5521
Netto-Cashflow:
$1.38B
1W Leistung:
+6.06%
1M Leistung:
-4.33%
6M Leistung:
+8.57%
1J Leistung:
+32.30%
1-Tages-Spanne:
$83.56
$85.21
1-Wochen-Bereich:
$78.78
$85.21
52-Wochen-Spanne:
$61.76
$91.06
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
83.89 | 40.78B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
210.67 | 148.71B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
20.50 | 14.13B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
45.28 | 13.48B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
46.55 | 9.62B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
What's in the offing for Ventas stock this earnings season? - MSN
O Shaughnessy Asset Management LLC Lowers Position in Ventas, Inc. $VTR - MarketBeat
Deutsche Bank AG Purchases 27,688 Shares of Ventas, Inc. $VTR - MarketBeat
BofA Securities Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $110 - Moomoo
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas stock (US92276F1003): healthcare REIT focuses on senior housing and medical offices - AD HOC NEWS
Ventas Inc Stock (US9227931050): Analyst Targets And Valuation Back In Focus After Recent Rally - AD HOC NEWS
Debra A. Cafaro, 55 - Crain's Chicago Business
Is Ventas Inc (VTR) Overvalued After 3.6% Rally? GF Value Says O - GuruFocus
Ventas stock (US92276F1003): Healthcare REIT focus after recent operating updates - AD HOC NEWS
Ventas Announces Second Quarter 2013 Earnings Release Date and Conference Call - AOL.com
Top 3 Real Estate Stocks Which Could Rescue Your Portfolio In JuneCareTrust REIT (NYSE:CTRE), Ventas - Benzinga
How Investors Are Reacting To Ventas (VTR) Reaffirming Its Dividend And Senior Housing Outlook - simplywall.st
Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch
Ventas Inc. stock (US92276F1003): Healthcare REIT focuses on senior housing recovery and portfolio o - AD HOC NEWS
A Look At Ventas (VTR) Valuation After Updated Outlook And Dividend Reaffirmation - Yahoo Finance
Ventas Inc stock (US9227931050): Healthcare REIT focuses on senior housing recovery and capital recy - AD HOC NEWS
Fjarde AP Fonden Fourth Swedish National Pension Fund Acquires New Stake in Ventas, Inc. $VTR - MarketBeat
Capital International Inc. CA Invests $8.43 Million in Ventas, Inc. $VTR - MarketBeat
(VTR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Ventas Inc. Stock Draws Aggressive Price Target Hikes - timothysykes.com
Vestcor Inc Lowers Stock Position in Ventas, Inc. $VTR - MarketBeat
Ventas expects $3.86 FFO per share in 2026 as it raises investment plan to $3B - MSN
Ventas Stock Climbs As Analysts Hike Price Targets And Guidance Holds - timothysykes.com
Insider Buying: Michael Embler Acquires Shares of Ventas Inc (VT - GuruFocus
Bank of New York Mellon Corp Buys 70,459 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Shares Bought by CIBC Asset Management Inc - MarketBeat
Ventas jumps as investors digest upbeat senior-housing update and 2026 outlook - Quiver Quantitative
Ventas director Michael Embler acquires $197,025 in company stock By Investing.com - Investing.com India
Ventas director Michael Embler acquires $197,025 in company stock - Investing.com
Ventas (VTR) director adds 2,500 shares in open-market purchase - Stock Titan
Daiwa Securities Group Inc. Has $364.12 Million Stake in Ventas, Inc. $VTR - MarketBeat
Cibc World Market Inc. Has $25.69 Million Holdings in Ventas, Inc. $VTR - MarketBeat
Top Ventas (VTR) Competitors 2026 - MarketBeat
Goldman Sachs Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $110 - Moomoo
Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit
REITs' fundamentals bode well for earnings outlook amid geopolitical uncertainty (DLR:NYSE) - Seeking Alpha
Ventas Stock Plummets 11% With 6-Day Losing Streak - Trefis
Ventas Stock 6-Day Losing Spree: Stock Falls -11% - Trefis
AVIP Intech U.S. Low Volatility Portfolio's Ventas Inc(VTR) Holding History - GuruFocus
Ventas Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement - New Castle News
Morgan Stanley Maintains Ventas Inc(VTR.US) With Hold Rating, Maintains Target Price $90 - 富途牛牛
Ventas Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Hazelview Securities Inc.'s Ventas Inc(VTR) Holding History - GuruFocus
Ventas VTR Q1 2026 Earnings Call Transcript - AOL.com
Norges Bank Buys Shares of 6,132,989 Ventas, Inc. $VTR - MarketBeat
Cbre Investment Management Listed Real Assets LLC Grows Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Forsta AP Fonden Decreases Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas Inc (VTR) Shares Fall 3.2% -- GF Value Says Still Overval - GuruFocus
VTR Maintained by Wells Fargo -- Price Target Raised to $96 - GuruFocus
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
1.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):